References
- 1 . Target populations for first-in-human embryonic stem cell research in spinal cord injury. Cell Stem Cell 8(5), 468–475 (2011).
- 2 Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label Phase 1/2 studies. Lancet 385(9967), 509–516 (2015).
- 3 Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report. Eur. Heart J. 36(30), 2011–2017 (2015).
- 4 . Japan stem-cell trial stirs envy. Nature 513(7518), 287–288 (2014).
- 5 . Patient-specific iPSC-derived RPE for modeling of retinal diseases. J. Clin. Med. 4(4), 567–578 (2015).
- 6 . Epidemiology and risk profile of heart failure. Nat. Rev. Cardiol. 8(1), 30–41 (2011).
- 7 Embryonic stem cell lines derived from human blastocysts. Science 282(5391), 1145–1147 (1998).
- 8 Automated mechanical passaging: a novel and efficient method for human embryonic stem cell expansion. Stem Cells 24(2), 230–235 (2006).
- 9 Derivation of xeno-free and GMP-grade human embryonic stem cells – platforms for future clinical applications. PLoS ONE 7(6), e35325 (2012).
- 10 Feeder-free growth of undifferentiated human embryonic stem cells. Nat. Biotechnol. 19(10), 971–974 (2001).
- 11 Recombinant human laminin isoforms can support the undifferentiated growth of human embryonic stem cells. Biochem. Biophys. Res. Commun. 375(1), 27–32 (2008).
- 12 . Culture of human pluripotent stem cells using completely defined conditions on a recombinant E-cadherin substratum. BMC Dev. Biol.
doi:10.1186/1471-213X-10-60 (2010) (Epub ahead of print). - 13 Materials for stem cell factories of the future. Nat. Mat. 13(6), 570–579 (2014).
- 14 Maintenance of pluripotency in human embryonic stem cells cultured on a synthetic substrate in conditioned medium. Biotechnol. Bioeng. 105(1), 130–140 (2010).
- 15 Discovery of a novel polymer for human pluripotent stem cell expansion and multilineage differentiation. Adv. Mat. 27(27), 4006–4012 (2015).
- 16 . Feeder layer- and serum-free culture of human embryonic stem cells. Biol. Reprod. 70(3), 837–845 (2004).
- 17 Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 24(2), 185–187 (2006).
- 18 Chemically defined conditions for human iPSC derivation and culture. Nat. Methods 8(5), 424–429 (2011).
- 19 Clonal culturing of human embryonic stem cells on laminin-521/E-cadherin matrix in defined and xeno-free environment. Nat. Commun. 5, 3195 (2014).
- 20 . Directed cardiomyogenesis of human pluripotent stem cells by modulating Wnt/beta-catenin and BMP signalling with small molecules. Biochem. J. 469(2), 235–241 (2015).
- 21 Unbiased screening of polymer libraries to define novel substrates for functional hepatocytes with inducible drug metabolism. Stem Cell Res. 6(2), 92–102 (2011).
- 22 A defined synthetic substrate for serum-free culture of human stem cell derived cardiomyocytes with improved functional maturity identified using combinatorial materials microarrays. Biomaterials 61, 257–265 (2015).
- 23 Creation of mouse embryonic stem cell-derived cardiac cell sheets. Biomaterials 32(30), 7355–7362 (2011).
- 24 Embryonic stem cell-derived cardiomyocyte heterogeneity and the isolation of immature and committed cells for cardiac remodeling and regeneration. Stem Cells Int. 2011, 214203 (2011).
- 25 Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510(7504), 273–277 (2014).
- 26 Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells. Nat. Methods
doi:10.1038/nmeth.3507 (2015) (Epub ahead of print). - 27 . A reproducible and versatile system for the dynamic expansion of human pluripotent stem cells in suspension. Biotechnol. J.
doi:10.1002/biot.201400757 (2015) (Epub ahead of print). - 28 Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture. Stem Cell Rep. 3(6), 1132–1146 (2014).
- 29 . Defined culture of human embryonic stem cells and xeno-free derivation of retinal pigmented epithelial cells on a novel, synthetic substrate. Stem Cells Transl. Med. 4(2), 165–177 (2015).
- 30 Allogeneic cell therapy bioprocess economics and optimization: single-use cell expansion technologies. Biotechnol. Bioeng. 111(1), 69–83 (2014).